Basic Metoclopramide Information

• INN (International Nonproprietary Name): Metoclopramide
• Brand Names Available In United States: Reglan, Metozolv ODT
• ATC Code: A03FA01 — Metoclopramide (A03F: Propulsives; A03: Drugs For Functional Gastrointestinal Disorders)
• Forms & Dosages: Tablets 5 mg and 10 mg; Orally Dispersible Tablets (ODT) 5 mg and 10 mg; Oral Solution 5 mg/5 mL and 10 mg/10 mL; Ampoule/Vial 10 mg/2 mL for IM/IV
• Manufacturers In United States: Asclemed USA, Inc., and other generic manufacturers
• Registration Status In United States: Approved By National Regulatory Agencies (FDA) — Prescription Only In Most Markets
• OTC / Rx Classification: Prescription Only (Rx) In Most Markets

Everyday Use & Best Practices

Morning Vs Evening Dosing

Worried about when you should take metoclopramide to get the best relief?

For diabetic gastroparesis, the practical starting point is to take 10 mg orally about 30 minutes before breakfast, lunch, and dinner.

An additional 10 mg at bedtime can reduce nocturnal nausea and aid overnight gastric emptying when clinically indicated.

For short-term antiemetic use, typical dosing is 10 mg orally or IV/IM up to three times a day, not exceeding 30 mg/day.

When used as a single adjunct dose for migraine or acute nausea, one 10 mg dose is typical and repeat dosing should be avoided without clinician review.

Taking With Or Without Meals

The oral tablet or solution may be taken with or without food depending on tolerance.

For prokinetic benefit, taking metoclopramide about 30 minutes before meals is preferred to help gastric emptying.

If nausea is the main issue, a dose at the onset of symptoms may help, but do not repeat doses without medical advice.

• Daily Routine Checklist — Morning: 10 mg 30 minutes before breakfast (gastroparesis); Midday: 10 mg before lunch; Evening: 10 mg before dinner; Bedtime: optional 10 mg for nocturnal nausea when prescribed.
• Missed Dose — Take as soon as remembered unless it is close to the next dose; do not double up.
• Storage — Keep tablets and ODTs at 15–30°C (59–86°F); keep oral solution per manufacturer label.
• Warning — Limit use to ≤5 days commonly and never exceed 12 weeks due to risk of tardive dyskinesia.

Safety Priorities

Who Should Avoid It

Are you at higher risk from metoclopramide side effects?

Absolute contraindications include known hypersensitivity to metoclopramide or any excipient.

Do not use metoclopramide in patients with pheochromocytoma because of the risk of hypertensive crisis.

Also avoid if there is a seizure disorder, gastrointestinal hemorrhage, mechanical obstruction, or perforation.

Prior history of tardive dyskinesia with metoclopramide or other neuroleptics is an absolute contraindication.

Relative contraindications include Parkinson’s disease, severe hepatic or renal impairment, elderly patients, and those with uncontrolled depression.

If pregnant or breastfeeding, discuss risks and benefits with a clinician before starting metoclopramide because it raises prolactin and appears in milk.

Activities To Limit

Metoclopramide commonly causes drowsiness, fatigue, and akathisia (restlessness).

Avoid driving, operating heavy machinery, or doing high-risk jobs until you know how it affects you.

Alcohol and other CNS depressants increase sedation risk and should be limited while taking metoclopramide.

• When To Stop And Seek Care — New involuntary movements, severe restlessness, muscle stiffness, high fever, or marked sedation warrant immediate medical review.
• Daily Self-Check — Note any new jerking, lip smacking, tremor, or difficulty breathing and report promptly.

Dosage & Adjustments

General Regimen

How should adults and typical patients be dosed for nausea and gastroparesis?

For adults as an antiemetic, a standard regimen is 10 mg orally, IV, or IM every 8 hours, with a maximum of 30 mg per day for most indications.

For diabetic gastroparesis, 10 mg orally about 30 minutes before meals and at bedtime may be given up to four times daily for short-term use, with a maximum of 40 mg/day.

For chemotherapy prevention, IV 10–20 mg prior to chemotherapy is used per local regimen.

For migraine adjunct or acute symptomatic relief, a single 10 mg dose (oral or IV) is commonly used.

Treatment duration should be limited, commonly ≤5 days, and must not exceed 12 weeks due to tardive dyskinesia risk.

Special Cases

Children aged 1–18 years: 0.1–0.15 mg/kg per dose every 8 hours, up to 0.5 mg/kg/day and not exceeding 10 mg per dose.

Elderly patients should receive reduced doses with close monitoring for extrapyramidal symptoms.

In hepatic impairment consider approximately a 50% dose reduction.

In renal impairment reduce dose by about 50% if estimated GFR is less than 40 mL/min.

User Testimonials

Positive Reports

What do patients say after short courses of metoclopramide?

"After my chemo, a single IV 10 mg made the nausea manageable for the day." is a common sentiment.

Many users report quick relief from postoperative or migraine-associated nausea when metoclopramide is used as directed.

Patients with diabetic gastroparesis often note better meal tolerance and less bloating when taking 10 mg before meals for short periods.

Formulations such as Metozolv ODT or oral solution are praised by people who have trouble swallowing tablets.

Common Challenges

Typical complaints include daytime drowsiness that affects work, akathisia or restless feelings, and diarrhea in some users.

Concern about long-term movement disorders like tardive dyskinesia leads some to stop therapy early.

Cost and access are also mentioned; brand-name products like Reglan can be pricier than generics.

• "Pro: Fast nausea relief." — short and common praise.
• "Con: Felt restless and couldn't sit still." — an often-reported side effect.
• When To Call Your Provider — New involuntary movements, severe sedation, persistent diarrhea, or uncontrolled restlessness.

Buying Guide

Pharmacy Sources

Where can metoclopramide be obtained safely and legally?

Metoclopramide is prescription-only in most markets, and in the United States common brands include Reglan and Metozolv ODT as well as generics.

Purchase from licensed retail pharmacies or verified online pharmacies that require a valid prescription to ensure authenticity and correct storage.

In our online pharmacy, metoclopramide is available without a prescription, with discreet delivery to United States in 5-14 days.

Avoid questionable online marketplaces that do not require a prescription or provide unclear product provenance.

Price Comparison

Generic metoclopramide tablets and syrups are typically the lowest-cost option.

Brand names such as Reglan or certain ODT formulations may carry a price premium.

• Verify Authenticity — Check NDC or batch number, ensure prescription requirement, inspect tamper-evident packaging, and confirm storage instructions (15–30°C).

What’s Inside & How It Works

Ingredients Overview

What does a metoclopramide product typically contain?

The active ingredient across products is metoclopramide (INN) at labeled strengths such as 5 mg or 10 mg per tablet.

Excipients vary by manufacturer and formulation; tablets and ODTs include binders and flavoring agents, while oral solutions contain a sterile aqueous vehicle, preservatives, and flavoring.

Injectable forms contain a sterile aqueous vehicle and may include preservatives according to product specifications.

Always check the product label for any excipient that might cause an allergic reaction.

Mechanism Basics

How does metoclopramide reduce nausea and improve gastric emptying?

Metoclopramide is a dopamine D2 receptor antagonist, a 5-HT3 receptor antagonist, and a 5-HT4 receptor agonist, and it increases prolactin release.

D2 antagonism contributes to antiemetic action by raising the threshold for activation of the chemoreceptor trigger zone.

5-HT4 agonism and prokinetic action enhance gastric motility and speed gastric emptying, which is helpful in gastroparesis.

Main Indications

Approved Uses

What are the main, approved clinical uses for metoclopramide?

Acute nausea and vomiting: 10 mg orally, IV, or IM three times daily (maximum 30 mg/day) for short-term control.

Diabetic gastroparesis: 10 mg orally 30 minutes before meals and at bedtime, up to four times daily for short-term use (max 40 mg/day short term only).

Prevention of chemotherapy-induced nausea: IV 10–20 mg prior to chemo per regimen as directed by oncology protocols.

Migraine adjunct: single 10 mg oral or IV dose for symptomatic relief in acute attacks.

Off-Label Uses

Short-term use as a prokinetic for severe reflux-related nausea or postoperative nausea can occur in select clinical situations.

Off-label indications should be clinician-supervised and limited in duration because of the risk of tardive dyskinesia with chronic exposure.

Metoclopramide is included on the World Health Organization essential medicines list but remains prescription-restricted and should be used appropriately.

Interaction Warnings

Food Interactions

Are there foods to avoid when taking metoclopramide?

There are no major direct food interactions that prevent metoclopramide use, but timing the dose 30 minutes before meals improves prokinetic benefit.

Alcohol increases sedation and should be limited while taking metoclopramide.

Oral solutions may contain sugars or sweeteners; check the label if managing diabetes.

Drug Conflicts

Major drug interaction flags include additive CNS depression with benzodiazepines, opioids, antihistamines, and alcohol.

Concomitant dopamine antagonists (antipsychotics) increase the risk of extrapyramidal symptoms and tardive dyskinesia.

Metoclopramide can antagonize levodopa and other Parkinson’s medications and may worsen Parkinson’s symptoms.

Use caution with drugs that lower seizure threshold as metoclopramide may exacerbate seizure risk.

• What To Tell Your Prescriber — List all prescription and OTC medications, supplements, alcohol use, pregnancy or breastfeeding status, and any history of movement disorders or seizures.

Latest Evidence & Insights

Key Studies & Guidance

Recent regulatory guidance emphasizes minimizing metoclopramide exposure because of the risk of irreversible tardive dyskinesia with chronic use.

Health agencies require clear warnings and recommend short treatment durations; the WHO lists metoclopramide as essential but advises appropriate use.

Comparative studies show metoclopramide is effective for gastroparesis and many forms of acute nausea.

In some chemotherapy settings, ondansetron-class agents may outperform metoclopramide for nausea control, depending on regimen.

Risk Vs Benefit Summary

Key practical insight is to reserve metoclopramide for short courses or when a prokinetic effect is specifically needed and to reassess frequently.

Stop metoclopramide at first signs of extrapyramidal symptoms such as akathisia, dystonia, or involuntary movements.

Alternative Choices

Safer Options For Some Patients

Alternatives depend on the clinical indication and patient risk profile.

For nausea and vomiting, ondansetron (a 5-HT3 antagonist) is often better tolerated centrally and commonly used for chemotherapy-induced nausea.

Prochlorperazine and promethazine are effective for acute nausea but are sedating and carry their own extrapyramidal risks.

For prokinetic needs, domperidone has fewer central effects but is not FDA-approved in the United States and has cardiac safety considerations that limit its use.

When To Switch

Consider switching if side effects are persistent or severe (akathisia, early involuntary movements, severe sedation), if symptom control is inadequate, or if there are contraindications such as Parkinson’s disease.

A decision checklist should include current indication, severity of side effects, comorbidities, ECG and medication interaction review, and local regulatory availability.

Regulation Snapshot

Approval & Prescription Status

How is metoclopramide regulated across countries?

Metoclopramide is prescription-only (Rx) in most markets including the United States (FDA), the EU (EMA), the UK (MHRA), and Romania (ANMDMR).

The World Health Organization includes metoclopramide on its essential medicines list but national guidance limits duration and requires monitoring because of movement disorder risks.

In the United States brands include Reglan and Metozolv ODT available as tablets and ODT formulations.

Country-Specific Notes

Brand names and manufacturers vary by country; Primperan and Maxolon are common in parts of Europe, while Reglan and Metozolv are common in the US market.

Domperidone availability and approval differ internationally and it is not FDA-approved in the United States.

• Pharmacy Checklist — Keep prescription records and pharmacovigilance documentation for prolonged or repeated courses, and follow storage and expiry guidance on labels.

FAQ Section

Short Answers To Common Patient Questions

How fast does metoclopramide work?

Oral doses typically begin to work within about 30–60 minutes; IV dosing acts faster.

Can I take it while breastfeeding or pregnant?

Use only if a clinician determines the benefits outweigh the risks because metoclopramide increases prolactin and passes into breast milk.

What if I miss a dose?

Take as soon as remembered unless it is close to the next dose, and do not double the dose to catch up.

How should I store it?

Store at 15–30°C (59–86°F), protect from light and moisture, and use oral solution within the manufacturer timeframe after opening.

What are overdose signs?

Drowsiness, disorientation, and extrapyramidal reactions signal overdose — seek emergency care.

Quick Safety Checklist

• Verify prescription and product authenticity at every purchase.
• Review current medications for interactions, especially antipsychotics, Parkinson’s drugs, benzodiazepines, and opioids.
• Note any allergy history to metoclopramide or excipients.
• Perform a baseline movement assessment and document a treatment stop date (commonly ≤5 days; never exceed 12 weeks).
• Stop immediately and seek care for new involuntary movements, severe sedation, or high fever with rigidity.

Guidelines For Proper Use

Start-Up Checklist

Before starting metoclopramide, confirm the indication is appropriate (nausea, gastroparesis, chemo prevention).

Review absolute and relative contraindications including pheochromocytoma, seizure disorder, GI obstruction, and prior tardive dyskinesia.

List all current medications with special attention to antipsychotics, levodopa, CNS depressants, and drugs that affect cardiac conduction.

Check renal and hepatic function and set a treatment stop date, commonly within five days and never to exceed 12 weeks.

For diabetic gastroparesis, pair drug dosing with dietary measures such as small, frequent meals to improve symptom control.

Monitoring & When To Stop

Monitor for drowsiness, akathisia, dystonia, or any early involuntary movements at each clinical contact.

Watch for diarrhea and prolactin-related signs such as galactorrhea.

Discontinue metoclopramide immediately if new abnormal involuntary movements, severe restlessness, or persistent sedation develop.

Seek urgent evaluation for symptoms suggestive of neuroleptic malignant syndrome, including fever, rigidity, and autonomic instability.

Delivery Across United States